The purpose of this study was to detect the possibility of drug interference in the estimation of urine protein in patients receiving therapeutic doses of penicillin G, ampicillin, methicillin, cefoxitin, cefazolin, gentamicin, co-trimoxazole, phenothiazines, glibenclamide and acetazolamide. Five different methods for urine protein determination were compared in these patients, when different amounts of albumin were added to urine in vitro, and in a control group of patients not treated witfi drugs known to interfere with these methods. The techniques included two semi-quantitative tests -a strip test (Albustix) and heat and acetic acid turbidity test; and three quantitative tests -sulphosalicylic acid test, trichloroacetic acid test and a test based on a formation of Ponceau S dye-protein complex (Urin-Pak).
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Mode of urine collection
On the day before urine collection, patients were given a disposable Container and were instructed to void into it their first urine speciraen, between 7 and 8 hours in the morning. pH was determined immediately upon collection of the samples and they were refrigerated until half an hour before protein measurement, later the same day. Different aliquots of urine were taken from the specimens depending on the test procedure. They ranged from 0.1 ml for the Ponceau S dye test to 5ml for the he t and acetic acid test.
Control group
Sixteen hospitalized adult patients not receiving any of the above medications or other medications known to affect urine protein determination.
Statistics
Urine protein values obtained by the different methods were compared by a method of analysis of variance with repeated raeasurements (8), using the BDMP program (9) . When it was found that at least one significant difterence between two paired means exists (p < 0.05), a further analysis with t test for paired samples was carried out to identify the significantly different pair.
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Results and Discussion
Comparison of the methods in vitro Table 2 demonstrates that the 3 quantitative methods for the estimation of urine protein are comparable. No significant difference among the mean values obtained with these methods was found when 0, 0.1 and 0.5 g/l of albumin were added. There was however, a tendency for the Ponceau S dye method to give false positive values in urine to which no protein was added and a tendency of the sulphosalicylic acid method to give higher readings with l .0 g/l of albumin (mean 1.05 versus 0.96 for trichloroacetic acid and 0.95 for Ponceau S dye, P < 0.05). The Ponceau S dye method was the most precise at this protein level (CV = 4.3%).
Comparison of the methods in control group
The means of urine protein by the sulphosalicylic acid, trichloroacetic acid and Ponceau S dye methods in the control group of patients did not differ significantly P > 0.05. The difference did not vary even when the 3 patients with grades 2 and 3 of protein, äs determined by the semi-quantitative methods, were excluded from analysis.
Comparison of the methods in patients receiving certain medications
The means of the determinations of urine protein values in patients receiving ampicillin, cefazolin, cefoxitin, co-trimoxazole and methicillin (in combination with penicillin G or glibenclamide), were not found to be statistically different in the 3 quantitative methods. As can be seen in table 3, in patients receiving therapeutic doses of acetazolamide, glibenclamide, penicillin G and phenothiazines, urine protein determination by the 3 quantitative methods differed significantly.
The differences arose from the Ponceau S dye method (c), which gave higher readings than those obtained by the sulphosalicylic acid method (a), or (except for the cases of glibenclamide and gentamicin) the trichloroacetic method (b). Most of the protein concentrations in the urine sample of patients receiving these drugs remained in the 0-0.15 g/l ränge and thus the differences cannot be considered clinically relevant. There were few individual concentrations exceeding this ränge up to 0.25 g/l by the Ponceau S dye method, but this still remained within the upper limit of "normal" urinary protein for this method. This does not exclude relevant clinical differences in patients with proteinuria. Gentamicin was the only drug which caused a relevant statistical and clinical effect leading to a reading of very high values of protein by the Ponceau S dye method. This verifies the results of Lievens & Celis (10) who studied the possible interference of gentamicin with the Ponceau S dye method. They found that at therapeutic concentrations gentamicin gave an apparent proteinuria with protein-free urine and increased the results by a factor of 2 to 4 when proteins were present. They did not find interference of gentamicin with a turbidimetric method, using sulphosalicylic acid or trichloroacetic acid. Lievens & Celis suggested that the precipitation of an insoluble salt of aminoglycosides with Ponceau S dye is the cause of the interference. They were able to eliminate the interference by changing the method slightly, precipitating urinary proteins first with trichloroacetic acid without Ponceau S dye (instead of with a mixture of the two), discarding the supernatant and then carrying out the original procedure on the precipitated protein redissolved in NaOH.
None of the semi-quantitative methods was found to be affected by the drugs under stucjy. Particularly noteworthy is the lack of effect of a drug eausing alkaluria (acetazolamide) on urine protein estimation by the Albustix method. This test is known to give false positive results in a very alkaline urine (11), however, none of the patients had a urine pH of 10 or above. We cpnclüde that methods other than Ponceau S dye for estimating urine protein shouid be used in patients receiving gentamicin therapy. Penicillin G, co-trimoxazole, glibenclanaide, acetazolamide and phenothiazines, contrary to suggestions in literature (1), were not shown to have a clinically relevant effect on any of the studied tests.
